Imcheck Therapeutics logo

Imcheck Therapeutics

Immuno-modulatory antibodies

4

Funding Rounds

$277.9m

Money raised

Overview

Immuno-modulatory antibodies

Funding

Funding series

Funding Series Analysis

The company Imcheck Therapeutics has raised a total of $277.85m in funding over 4 rounds.

Key Insights:

  • Imcheck Therapeutics Series C round, June 2022: $103m
  • ImCheck Therapeutics June 2022 Funding Round: $100m
  • ImCheck Therapeutics Series B round, December 2019: $53m
  • ImCheck Therapeutics Series A round, May 2017: $21.85m
Imcheck Therapeutics logo
Imcheck Therapeutics Series C round, June 2022 $103m
Imcheck Therapeutics logo
ImCheck Therapeutics June 2022 Funding Round $100m
Imcheck Therapeutics logo
ImCheck Therapeutics Series B round, December 2019 $53m
Imcheck Therapeutics logo
ImCheck Therapeutics Series A round, May 2017 $21.85m